Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mora

Showing results (221-230 of 238) with videos related to

Pageof 24
Sort By:
Biorxiv : the Preprint Server for Biology|December 9, 2024
Sex-specific DNA methylation differences in Amyotrophic lateral sclerosisOlivia A Grant, Alfredo Iacoangeli, Ramona A J Zwamborn, et al.
Science Translational Medicine|December 20, 2019
Human genetics and neuropathology suggest a link between miR-218 and amyotrophic lateral sclerosis pathophysiologyIrit Reichenstein, Chen Eitan, Sandra Diaz-Garcia, et al.
Nature Communications|July 2, 2024
Author Correction: The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease durationSarah Opie-Martin, Alfredo Iacoangeli, Simon D Topp, et al.
Nature Communications|November 13, 2022
The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease durationSarah Opie-Martin, Alfredo Iacoangeli, Simon D Topp, et al.
Frontiers in Cellular Neuroscience|January 2, 2023
Telomere length analysis in amyotrophic lateral sclerosis using large-scale whole genome sequence dataAhmad Al Khleifat, Alfredo Iacoangeli, Ashley R Jones, et al.
NPJ Genomic Medicine|January 29, 2022
Structural variation analysis of 6,500 whole genome sequences in amyotrophic lateral sclerosisAhmad Al Khleifat, Alfredo Iacoangeli, Joke J F A van Vugt, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 24, 2020
A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of <i>Reldesemtiv</i> In Patients With ALSJeremy M Shefner, Jinsy A Andrews, Angela Genge, et al.
Human Mutation|September 1, 2012
Analysis of the C9orf72 gene in patients with amyotrophic lateral sclerosis in Spain and different populations worldwideAlberto García-Redondo, Oriol Dols-Icardo, Ricard Rojas-García, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 17, 2022
Clinical trials in pediatric ALS: a TRICALS feasibility studyTessa Kliest, Ruben P A Van Eijk, Ammar Al-Chalabi, et al.
Lupus|April 28, 2026
Treatment patterns and outcomes of first lupus nephritis episode over 25 years in two Latin American cohortsRosana Quintana, Lucia Hernández, Guillermo Pons-Estel, et al.
Pageof 24

Showing results (221-230 of 238) with videos related to

Sort By:
Pageof 24
Biorxiv : the Preprint Server for Biology|December 9, 2024
Sex-specific DNA methylation differences in Amyotrophic lateral sclerosisOlivia A Grant, Alfredo Iacoangeli, Ramona A J Zwamborn, et al.
Science Translational Medicine|December 20, 2019
Human genetics and neuropathology suggest a link between miR-218 and amyotrophic lateral sclerosis pathophysiologyIrit Reichenstein, Chen Eitan, Sandra Diaz-Garcia, et al.
Nature Communications|July 2, 2024
Author Correction: The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease durationSarah Opie-Martin, Alfredo Iacoangeli, Simon D Topp, et al.
Nature Communications|November 13, 2022
The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease durationSarah Opie-Martin, Alfredo Iacoangeli, Simon D Topp, et al.
Frontiers in Cellular Neuroscience|January 2, 2023
Telomere length analysis in amyotrophic lateral sclerosis using large-scale whole genome sequence dataAhmad Al Khleifat, Alfredo Iacoangeli, Ashley R Jones, et al.
NPJ Genomic Medicine|January 29, 2022
Structural variation analysis of 6,500 whole genome sequences in amyotrophic lateral sclerosisAhmad Al Khleifat, Alfredo Iacoangeli, Joke J F A van Vugt, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 24, 2020
A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of <i>Reldesemtiv</i> In Patients With ALSJeremy M Shefner, Jinsy A Andrews, Angela Genge, et al.
Human Mutation|September 1, 2012
Analysis of the C9orf72 gene in patients with amyotrophic lateral sclerosis in Spain and different populations worldwideAlberto García-Redondo, Oriol Dols-Icardo, Ricard Rojas-García, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 17, 2022
Clinical trials in pediatric ALS: a TRICALS feasibility studyTessa Kliest, Ruben P A Van Eijk, Ammar Al-Chalabi, et al.
Lupus|April 28, 2026
Treatment patterns and outcomes of first lupus nephritis episode over 25 years in two Latin American cohortsRosana Quintana, Lucia Hernández, Guillermo Pons-Estel, et al.
Pageof 24